New hope for bile duct cancer: drug may delay return after surgery and chemo
NCT ID NCT07260175
First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times
Summary
This study tests a drug called ivosidenib in people with a specific type of bile duct cancer (IDH1-mutated) that has been surgically removed. After standard chemotherapy, participants take ivosidenib daily to see if it helps keep the cancer from returning. The trial involves 40 adults and will measure how many are cancer-free after one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asklepios Tumorzentrum Hamburg
RECRUITINGHamburg, 22763, Germany
-
Klinikum Oldenburg AöR
RECRUITINGOldenburg, 26133, Germany
-
Klinikum rechts der Isar TU München
RECRUITINGMünchen, 81675, Germany
-
Krankenhaus Barmherzige Brüder Regensburg
RECRUITINGRegensburg, 93049, Germany
-
Krankenhaus Nordwest
RECRUITINGFrankfurt, 60488, Germany
-
LMU Klinikum Großhadern
RECRUITINGMünchen, 81377, Germany
-
Uniklinik RWTH Aachen
RECRUITINGAachen, 52074, Germany
-
Uniklinikum Essen
RECRUITINGEssen, 45147, Germany
-
Uniklinikum Jena
RECRUITINGJena, 7747, Germany
-
Universitätsklinik Gießen und Marburg GmbH Standort Gießen
RECRUITINGGiessen, 35392, Germany
-
Universitätsklinikum Bonn
RECRUITINGBonn, 53127, Germany
-
Universitätsklinikum Frankfurt
RECRUITINGFrankfurt, 60590, Germany
-
Universitätsklinikum Mannheim
RECRUITINGMannheim, 68167, Germany
-
Universitätsmedizin Göttingen
RECRUITINGGöttingen, 37099, Germany
-
Universitätsmedizin Mainz
RECRUITINGMainz, 55131, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sound waves supercharge immunotherapy against bile duct cancer?
- A new test could reveal how radiation affects the liver
- Can blood tests reveal how liver and bile duct cancers respond to treatment?
- Can a smart drug home in on Hard-to-Treat GI cancers?
- Can a pill target Hard-to-Treat bile duct cancers? a new drug puts FGFR2 mutations to the test
- Can matching drugs to tumor genes beat biliary cancer?